FDA approves first generic capecitabine to treat breast and colorectal cancers
On Sept. 16, the U.S. Food and Drug Administration (FDA) approved the first generic version of Xeloda (capecitabine), used to treat metastatic breast and…
Gastroenterology
Study: Regular colonoscopy screening could prevent 40% of colorectal cancers
Regular colonoscopy screening could prevent 40% of colorectal cancers, according to a study in the New England Medical Journal that followed 88,902 participants from…
Study: Dementia increases risk of incontinence
A UK study in PLOS Medicine found that people with dementia have about three times the rate of urinary incontinence and more than four…
Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection
The author describes an innovative technique that is helping patients with C. difficile infection, including patient selection; care before, during, and after the procedure;…
FDA approves Simponi for ulcerative colitis
May 15, the U.S. Food and Drug Administration (FDA) approved a new use for Simponi (golimumab) injection: to treat adults with moderate to severe…
Questioning common nursing practices: What does the evidence show?
To improve patient outcomes, nurses need to challenge practice traditions.
From our readers…Value all your skills
Anyone who’s been a nurse for more than 10 years will agree with me: you can make big leaps from specialty to specialty and…
A new surgical intervention for reflux treatment
Learn about LINX, a surgical procedure for treating chronic gastroesophageal reflux disease.
FDA approves first anti-diarrheal drug for HIV/AIDS patients
On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients taking antiretroviral…
Study: Donor feces more effective than vancomycin in treatment of recurrent C. difficile
A study in The New England Journal of Medicine found that infusing a solution of donor feces through a nasoduodenal tube was “significantly more…
Study: Health care organizations reduce SSIs by nearly half with Joint Commission project
A 2.5-year project under the direction of the Joint Commission Center for Transforming Healthcare in collaboration with the American College of Surgeons reduced surgical…
FDA approves new drug for irritable bowel syndrome and constipation
On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable bowel syndrome…
FDA approves first generic capecitabine to treat breast and colorectal cancers
On Sept. 16, the U.S. Food and Drug Administration (FDA) approved the first generic version of Xeloda (capecitabine), used to treat metastatic…
Study: Regular colonoscopy screening could prevent 40% of colorectal cancers
Regular colonoscopy screening could prevent 40% of colorectal cancers, according to a study in the New England Medical Journal that followed 88,902…
Study: Dementia increases risk of incontinence
A UK study in PLOS Medicine found that people with dementia have about three times the rate of urinary incontinence and more…
Fecal microbiota transplantation: Breaking the chain of recurrent C. difficile infection
The author describes an innovative technique that is helping patients with C. difficile infection, including patient selection; care before, during, and after…
FDA approves Simponi for ulcerative colitis
May 15, the U.S. Food and Drug Administration (FDA) approved a new use for Simponi (golimumab) injection: to treat adults with moderate…
Questioning common nursing practices: What does the evidence show?
To improve patient outcomes, nurses need to challenge practice traditions.
From our readers…Value all your skills
Anyone who’s been a nurse for more than 10 years will agree with me: you can make big leaps from specialty to…
A new surgical intervention for reflux treatment
Learn about LINX, a surgical procedure for treating chronic gastroesophageal reflux disease.
FDA approves first anti-diarrheal drug for HIV/AIDS patients
On Dec. 31, 2012, the U.S. Food and Drug Administration (FDA) approved Fulyzaq (crofelemer) to relieve symptoms of diarrhea in HIV/AIDS patients…
Study: Donor feces more effective than vancomycin in treatment of recurrent C. difficile
A study in The New England Journal of Medicine found that infusing a solution of donor feces through a nasoduodenal tube was…
Study: Health care organizations reduce SSIs by nearly half with Joint Commission project
A 2.5-year project under the direction of the Joint Commission Center for Transforming Healthcare in collaboration with the American College of Surgeons…
FDA approves new drug for irritable bowel syndrome and constipation
On Aug. 30, the U.S. Food and Drug Administration (FDA) approved Linzess (linaclotide) to treat chronic idiopathic constipation and to treat irritable…
Poll
Preferred way to get content
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.